{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:51:49Z","timestamp":1792443109210,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41591-018-0130-7","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T12:17:33Z","timestamp":1532521053000},"page":"1430-1440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound"],"prefix":"10.1038","volume":"24","author":[{"given":"Afam A.","family":"Okoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick M.","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail B.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4686-830X","authenticated-orcid":false,"given":"David","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne M.","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred W.","family":"Legasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hesselgesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romas","family":"Geleziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-9214","authenticated-orcid":false,"given":"Randy","family":"Fast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Bosche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh R.","family":"Borate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8393-8103","authenticated-orcid":false,"given":"Paul T.","family":"Edlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1984-5906","authenticated-orcid":false,"given":"Michael K.","family":"Axthelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Picker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"130_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","volume":"14","author":"MJ Churchill","year":"2016","unstructured":"Churchill, M. J. et al. HIV reservoirs: What, where and how to target them. Nat. Rev. Microbiol. 14, 55\u201360 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"130_CR2","first-page":"262","volume":"8","author":"GQ Del Prete","year":"2013","unstructured":"Del Prete, G. Q. & Lifson, J. D. Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies. Curr. Opin. HIV AIDS 8, 262\u2013272 (2013).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"130_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nm.3781","volume":"21","author":"Y Fukazawa","year":"2015","unstructured":"Fukazawa, Y. et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat. Med. 21, 132\u2013139 (2015).","journal-title":"Nat. Med."},{"key":"130_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tim.2016.02.006","volume":"24","author":"B Miles","year":"2016","unstructured":"Miles, B. & Connick, E. TFH in HIV latency and as sources of replication-competent virus. Trends Microbiol. 24, 338\u2013344 (2016).","journal-title":"Trends Microbiol."},{"key":"130_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.1600343","volume":"197","author":"AJ Murray","year":"2016","unstructured":"Murray, A. J. et al. The latent reservoir for HIV-1: How immunologic memory and clonal expansion contribute to HIV-1 persistence. J. Immunol. 197, 407\u2013417 (2016).","journal-title":"J. Immunol."},{"key":"130_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6517a5","volume":"65","author":"Announcement.","year":"2016","unstructured":"Announcement. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV\u2014United States, 2016. MMWR Morb. Mortal. Wkly Rep. 65, 458 (2016).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"130_CR7","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1128\/JVI.74.6.2584-2593.2000","volume":"74","author":"JD Lifson","year":"2000","unstructured":"Lifson, J. D. et al. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J. Virol. 74, 2584\u20132593 (2000).","journal-title":"J. Virol."},{"key":"130_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature13594","volume":"512","author":"JB Whitney","year":"2014","unstructured":"Whitney, J. B. et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512, 74\u201377 (2014).","journal-title":"Nature"},{"key":"130_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMc1413931","volume":"372","author":"K Luzuriaga","year":"2015","unstructured":"Luzuriaga, K. et al. Viremic relapse after HIV-1 remission in a perinatally infected child. N. Engl. J. Med. 372, 786\u2013788 (2015).","journal-title":"N. Engl. J. Med."},{"key":"130_CR10","doi-asserted-by":"publisher","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","volume":"14","author":"TJ Henrich","year":"2017","unstructured":"Henrich, T. J. et al. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 14, e1002417 (2017).","journal-title":"PLoS Med."},{"key":"130_CR11","doi-asserted-by":"crossref","unstructured":"Colby, D. J. et al. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat. Med. 24, 923\u2013926 (2018).","DOI":"10.1038\/s41591-018-0026-6"},{"key":"130_CR12","unstructured":"Luzuriaga, K. et al. Absent HIV-specific immune responses and replication-competent HIV reservoirs in perinatally infected youth treated from infancy: Towards cure. In 20th Conference on Retroviruses and Opportunistic Infections; March 3\u20136, Atlanta, GA, abstract 171LB (2013)."},{"key":"130_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","volume":"369","author":"D Persaud","year":"2013","unstructured":"Persaud, D. et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N. Engl. J. Med. 369, 1828\u20131835 (2013).","journal-title":"N. Engl. J. Med."},{"key":"130_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature10003","volume":"473","author":"SG Hansen","year":"2011","unstructured":"Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523\u2013527 (2011).","journal-title":"Nature"},{"key":"130_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature12519","volume":"502","author":"SG Hansen","year":"2013","unstructured":"Hansen, S. G. et al. Immune clearance of highly pathogenic SIV infection. Nature 502, 100\u2013104 (2013).","journal-title":"Nature"},{"key":"130_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nm.1935","volume":"15","author":"SG Hansen","year":"2009","unstructured":"Hansen, S. G. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15, 293\u2013299 (2009).","journal-title":"Nat. Med."},{"key":"130_CR17","doi-asserted-by":"publisher","first-page":"1237874","DOI":"10.1126\/science.1237874","volume":"340","author":"SG Hansen","year":"2013","unstructured":"Hansen, S. G. et al. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340, 1237874 (2013).","journal-title":"Science"},{"key":"130_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1126\/science.aac9475","volume":"351","author":"SG Hansen","year":"2016","unstructured":"Hansen, S. G. et al. Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E. Science 351, 714\u2013720 (2016).","journal-title":"Science"},{"key":"130_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1089\/aid.2015.0003","volume":"31","author":"WK Kim","year":"2015","unstructured":"Kim, W. K. et al. Increased expression of CD169 on blood monocytes and its regulation by virus and CD8 T cells in macaque models of HIV infection and AIDS. AIDS Res. Hum. Retrovir. 31, 696\u2013706 (2015).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"130_CR20","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1371\/journal.pone.0000257","volume":"2","author":"AC van der Kuyl","year":"2007","unstructured":"van der Kuyl, A. C. et al. Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression. PLoS One 2, e257 (2007).","journal-title":"PLoS One"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1128\/jvi.71.10.7518-7525.1997","volume":"71","author":"MA Nowak","year":"1997","unstructured":"Nowak, M. A. et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71, 7518\u20137525 (1997).","journal-title":"J. Virol."},{"key":"130_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/aid.2015.0130","volume":"32","author":"GQ Del Prete","year":"2016","unstructured":"Del Prete, G. Q. et al. Short communication: Comparative evaluation of coformulated injectable combination antiretroviral therapy regimens in simian immunodeficiency virus-infected rhesus macaques. AIDS Res. Hum. Retrovir. 32, 163\u2013168 (2016).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"130_CR23","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1128\/JVI.01026-14","volume":"88","author":"GQ Del Prete","year":"2014","unstructured":"Del Prete, G. Q. et al. Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events. J. Virol. 88, 8077\u20138090 (2014).","journal-title":"J. Virol."},{"key":"130_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1084\/jem.20090356","volume":"206","author":"A Okoye","year":"2009","unstructured":"Okoye, A. et al. Profound CD4+\/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206, 1575\u20131588 (2009).","journal-title":"J. Exp. Med."},{"key":"130_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.283.5403.857","volume":"283","author":"JE Schmitz","year":"1999","unstructured":"Schmitz, J. E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857\u2013860 (1999).","journal-title":"Science"},{"key":"130_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aab3886","volume":"349","author":"DH Barouch","year":"2015","unstructured":"Barouch, D. H. et al. Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys. Science 349, 320\u2013324 (2015).","journal-title":"Science"},{"key":"130_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","volume":"353","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus. Science 353, 1045\u20131049 (2016).","journal-title":"Science"},{"key":"130_CR28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/infdis\/jit086","volume":"207","author":"TJ Henrich","year":"2013","unstructured":"Henrich, T. J. et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J. Infect. Dis. 207, 1694\u20131702 (2013).","journal-title":"J. Infect. Dis."},{"key":"130_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature22984","volume":"547","author":"SG Hansen","year":"2017","unstructured":"Hansen, S. G. et al. Addendum: Immune clearance of highly pathogenic SIV infection. Nature 547, 123\u2013124 (2017).","journal-title":"Nature"},{"key":"130_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.4156","volume":"22","author":"KM Bruner","year":"2016","unstructured":"Bruner, K. M. et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22, 1043\u20131049 (2016).","journal-title":"Nat. Med."},{"key":"130_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C. et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\u2013551 (2013).","journal-title":"Cell"},{"key":"130_CR32","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/nm.2934","volume":"18","author":"Y Fukazawa","year":"2012","unstructured":"Fukazawa, Y. et al. Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat. Med. 18, 1673\u20131681 (2012).","journal-title":"Nat. Med."},{"key":"130_CR33","doi-asserted-by":"publisher","first-page":"e1006283","DOI":"10.1371\/journal.ppat.1006283","volume":"13","author":"JK Bui","year":"2017","unstructured":"Bui, J. K. et al. Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir. PLoS Pathog. 13, e1006283 (2017).","journal-title":"PLoS Pathog."},{"key":"130_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1084\/jem.20170193","volume":"214","author":"NN Hosmane","year":"2017","unstructured":"Hosmane, N. N. et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics. J. Exp. Med. 214, 959\u2013972 (2017).","journal-title":"J. Exp. Med."},{"key":"130_CR35","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1073\/pnas.1600097113","volume":"113","author":"M Kim","year":"2016","unstructured":"Kim, M. & Siliciano, R. F. Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection. Proc. Natl Acad. Sci. USA 113, 1692\u20131694 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"130_CR36","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1172\/JCI95329","volume":"127","author":"KJ Kwon","year":"2017","unstructured":"Kwon, K. J. & Siliciano, R. F. HIV persistence: Clonal expansion of cells in the latent reservoir. J. Clin. Invest. 127, 2536\u20132538 (2017).","journal-title":"J. Clin. Invest."},{"key":"130_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.1254194","volume":"345","author":"F Maldarelli","year":"2014","unstructured":"Maldarelli, F. et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179\u2013183 (2014).","journal-title":"Science"},{"key":"130_CR38","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1073\/pnas.1522675113","volume":"113","author":"FR Simonetti","year":"2016","unstructured":"Simonetti, F. R. et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc. Natl Acad. Sci. USA 113, 1883\u20131888 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"130_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","volume":"22","author":"AJ Hessell","year":"2016","unstructured":"Hessell, A. J. et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat. Med. 22, 362\u2013368 (2016).","journal-title":"Nat. Med."},{"key":"130_CR40","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1128\/JVI.00895-07","volume":"81","author":"JT Loffredo","year":"2007","unstructured":"Loffredo, J. T. et al. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81, 8827\u20138832 (2007).","journal-title":"J. Virol."},{"key":"130_CR41","doi-asserted-by":"publisher","first-page":"E3413","DOI":"10.1073\/pnas.1606636113","volume":"113","author":"H Li","year":"2016","unstructured":"Li, H. et al. Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques. Proc. Natl Acad. Sci. USA 113, E3413\u2013E3422 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"130_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0684.2005.00128.x","volume":"34","author":"AN Cline","year":"2005","unstructured":"Cline, A. N. et al. Highly sensitive SIV plasma viral load assay: Practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34, 303\u2013312 (2005).","journal-title":"J. Med. Primatol."},{"key":"130_CR43","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2353\/ajpath.2008.070967","volume":"172","author":"S Venneti","year":"2008","unstructured":"Venneti, S. et al. Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration. Am. J. Pathol. 172, 1603\u20131616 (2008).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0130-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:41:08Z","timestamp":1733960468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0130-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0130-7","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Oregon Health & Science University, L.J.P., and S.G.H. have a financial interest in Vir Biotechnology, Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and managed by Oregon Health & Science University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}